FDA Approved: ZOLMITRIPTAN — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approves Cipla USA Inc.'s original ANDA for zolmitriptan, authorizing the marketing of a generic zolmitriptan product for migraine treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Zolmitriptan (zolmitriptan)

Snippet

ORIG AP for ZOLMITRIPTAN (ZOLMITRIPTAN)